Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis

NCT03040427 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03040427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03040427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2017
Completion date
August 21, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis